BSEAGM/EGM24 Aug 2026 · 24 Aug 2026, 05:09 pm

Dear Sir/Madam, The 24th Annual General Meeting of M/s. Prism Medico and Pharmacy is scheduled to be held on 19th September, 2026 through VC/OAVM. The notice of the same is attached ....

Prism Medico and Pharmacy Ltd · 512217

✦ AI SummaryResults

Prism Medico and Pharmacy Ltd has scheduled its 24th Annual General Meeting (AGM) on September 19, 2026, through video conferencing. The meeting will consider the audited standalone financial statements for the year ended March 31, 2026, and other business items.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Prism Medico and Pharmacy Ltd - 512217 - Notice Of 24Th Annual General Meeting.

Attachments (1)

📄

03c22445-d365-4acd-9c90-a8a6e9dc7e15.pdf

pdf

Download →
View document text
PRISM MEDICO AND PHARMACY LIMITED CIN: L24100HP2002PLC009299; Email Id: investorgrievancewmcl@gmail.com Registered Office: Suketi Road, Kala Amb, Sirmaur, Himachal Pradesh-173030. Date: 24.08.2026 To, T o, Department of Corporate Services, Listing Department, BSE LIMITED Metropolitan Stock Exchange of India Limited P. J. Towers, Dalal Street, (MSE]) - Mumbai, Maharashtra-400001. Vibgyor Towers, 4 Floor, Plot Number C 62, G - Block, Opposite Trident Hotel, Bandra Kurla Complex, ISIN : INE730E01016 Bandra (E), Mumbai, Maharashtra—400098. Scrip Code: 512217 SYMBOL: PRISMMEDI Subject: Notice of 24» Annual General Meeting. Reference: Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. Dear Sir/Madam, In compliance with Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith Notice of 24 Annual General Meeting of the members of the company scheduled to be held on Saturday, the 19% day of September, 2026 at 12:30 P.M. through Video Conferencing (“VC”)/Other Audio Visual Means (“OAVM”). You are requested to kindly take the same on record and oblige. Thanking You. Yours Truly, FOR PRISM MEDICO AND PHARMACY LIMITED a, iA ff /upl efea j: ooty pp Laer “DAVENDER SINGH BIRECTOR DIN: 09447213 PRISM MEDICO PHARMACY LIMITED NOTICE OF ANNUAL GENERAL MEETING 2025-2026 1 | P age NOTICE CONVENING THE 24TH ANNUAL GENERAL MEETING NOTICE IS HEREBY GIVEN THAT THE 24TH ANNUAL GENERAL MEETING OF THE MEMBERS OF PRISM MEDICO AND PHARMACY LIMITED WILL BE HELD ON SATURDAY, THE 19TH DAY OF SEPTEMBER 2026, AT 12:30 P.M. THROUGH VIDEO CONFERENCING (VC)/OTHER AUDIO VISUAL MEANS (OAVM) FACILITY TO TRANSACT THE FOLLOWING BUSINESS:  ORDINARY BUSINESS: 1. To receive, consider and adopt the Audited Standalone Financial Statements of the company for the financial year ended 31st March, 2026, together with the Reports of the Board of Directors and Auditors thereon. 2. To appoint a Director in place of Mr. Davender Singh (DIN: 09447213), who retires by rotation and being eligible, offers himself for re-appointment. 3. To consider and if thought fit, to pass, the following resolution as an Ordinary Resolution: To re-appoint M/s. Garg Mendiratta and Associates, Chartered Accountants as the statutory auditors of the company and fix their remuneration. “RESOLVED THAT pursuant to the provisions of Section 139, 141 and 142 and all other applicable provisions, of the Companies Act, 2013 (“the Act”) and Rules made there under (including any statutory modification(s) or re-enactment thereof for the time being in force), the consent and approval of the members of the company be and is hereby given for the re-appointment of M/s. Garg Mendiratta and Associates, Chartered Accountants as the statutory auditors of the company to hold the office from the conclusion of this Annual General Meeting until the conclusion of the next Annual General Meeting to be held for the financial year 2026-2027 at such remuneration and all out of pocket expenses as may be decided between the Board of Directors and M/s. Garg Mendiratta and Associates, Chartered Accountants.” “RESOLVED FURTHER THAT the Board of Directors of the Company be and are hereby authorized to do all such acts, deeds and action as may be necessary, proper or expedient to give effect to this resolution.”  SPECIAL BUSINESS: 4. To consider and if thought fit, to pass, the following Resolution as an Ordinary Resolution: To appoint M/S. SDK & Associates, Practicing Company Secretaries as the Secretarial Auditors of the Company for a period of five financial years from financial year 2026-2027 to financial year 2030-2031. “RESOLVED THAT pursuant to the provision of Section 204 of the Companies Act, 2013, read with Rule 9 of the Companies (Appointment and Remuneration of Managerial Personnel) Rules, 2014, Regulation 24A of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (including any statutory modification(s), enactment(s) or re-enactment(s) thereof, for the time being in force) the consent and approval of the members of the company be and is hereby accorded for the appointment of M/s. SDK & Associates, Practicing Company Secretaries, a peer reviewed firm (Peer Review Certificate Number 7065/2025) as the Secretarial Auditors of the Company for a term of five consecutive financial years commencing from the financial year 2026-2027 to financial year 2030-2031, on such remuneration to be decided by the Board of Directors in consultation with Secretarial Auditors from time to time.” “RESOLVED FURTHER THAT the Board of Directors of the Company be and are hereby authorized to do all such acts, deeds, matters and things as may be considered necessary, desirable or expedient to give effect to 2 | P age this resolution.” 5. To consider and if thought fit, to pass, the following resolution as a Special Resolution: To approve variation in the objects of the Preferential Issue and in the utilisation of the proceeds thereof, as approved by the members at the Extraordinary General Meeting held on March 20, 2026. "RESOLVED THAT pursuant to the provisions of Sections 23, 42, 62 and all other applicable provisions, if any, of the Companies Act, 2013 ("the Act") read with the Rules made thereunder (including any statutory modification(s) or re-enactment thereof for the time being in force), the applicable provisions of the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, as amended ("SEBI ICDR Regulations"), Regulation 32 and all other applicable provisions of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended from time to time ("SEBI Listing Regulations"), the provisions of the Memorandum and Articles of Association of the Company, and subject to such other approvals, consents, permissions and sanctions as may be required, and on the recommendation of the Audit Committee and the Board of Directors, the consent and approval of the Members of the Company be and is hereby accorded to vary the objects of the preferential issue of 75,00,000 Equity Shares and 50,00,000 Convertible Warrants approved by the Members at the Extraordinary General Meeting held on March 20, 2026 (as modified by the Corrigendum to the said Notice dated March 18, 2026) and allotted by the Board of Directors on May 05, 2026, and the utilisation of the proceeds thereof, in the manner set out in the table below: S. No. Original Object (as per Original Revised Object Amount Revised allocation / Notice dated February 23, Allocation utilised till balance to be 2026 read with (Rs.) date (Rs.) utilised (Rs.) Corrigendum dated March 18, 2026) 1. Plant and Machineries for 15,69,00,000 Object discontinued Nil Nil manufacturing of Medicines 2. Civil structures including 7,31,00,000 Object discontinued Nil Nil foundation, RCC work, brick walls, security cabin, outer boundary wall, PEB dome structure shed, technical flooring, painting, land filling, kharkuwa, underground tank, drainage chamber, tiles, Kota stone flooring, etc. 3. Purchase of Land and 1,00,00,000 No change 1,00,00,000 Nil Building situated at Nagal Suket, Tehsil Nahan, District Sirmaur, Himachal Pradesh – 173001 4. General corporate 1,00,00,000 No change Nil 1,00,00,000 purposes 5. Not originally envisaged Nil Strategic Nil 23,00,00,000 investment by way of subscription to freshly issued 3 | P age S. No. Original Object (as per Original Revised Object Amount Revised allocation / Notice dated February 23, Allocation utilised till balance to be 2026 read with (Rs.) date (Rs.) utilised (Rs.) Corrigendum dated March 18, 2026) Equity Shares of Infuze Well Private Limited ("IWPL"), a related party, resulting in Infuze Well Private Limited becoming a subsidiary of the Company TOTAL 25,00,00,000 1,00,00,000 24,00,00,000 "RESOLVED [Showing first 8,000 characters — download PDF for full document]